In October 2024, Blue Cross Blue Shield (“BCBS”)
agreed to a $2.8 billion settlement to resolve allegations of
anti-competitive practices in the health insurance market –
it is reported to be the largest settlement in a health care
antitrust case to date. This landmark case has drawn significant
attention from policymakers, health care advocates, and consumers
alike, highlighting the complexities of the health care system and
its relationship with fair competition.
The settlement stemmed from a class action lawsuit filed in
2012, which accused BCBS of engaging in practices that limited
competition among its member companies. The plaintiffs argued that
BCBS's licensing agreements, which allowed local insurers to
use the BCBS brand, divided the country into exclusive areas, which
effectively insulated them from competing with each other. For
example, it was alleged that certain plans had monopolies in their
state on the Blues brand, national employers who sought out a
